Naranjargal Daivaa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Naranjargal Daivaa has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra G. Bell
Department of Molecular Biology, Princeton University , Princeton, NJ 08544
1 shared publication - Cameron Myhrvold
Princeton University
1 shared publication - Deninson Alejandro Vargas
Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM)
1 shared publication - John Lucian Davis
Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
1 shared publication - Nisha H. Modi
Public Health Research Institute, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA
1 shared publication - Owen R. S. Dunkley
Department of Molecular Biology, Princeton University, Princeton NJ 08544, USA
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 8 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (32) , eadx2067
A streamlined CRISPR-based test for tuberculosis detection directly from sputum
Mycobacterium tuberculosis ( Mtb ) is a major threat to global health, and there is an urgent need for affordable, simple tuberculosis (TB) diagnosis in underresourced areas. Here, we combine recombinase polymerase amplification with Cas13a and Cas12a detection to create two parallelized one-pot assays that detect two conserved elements of Mtb ( IS6110 and IS1081 ) and a human DNA internal control. These assays are compatible with lateral flow and can be readily lyophilized. Our final assay showed a limit of detection of 69.0 CFU per milliliter for Mtb H37Rv and 80.5 CFU per milliliter for Mycobacterium bovis BCG in spiked sputum, with no cross-reactivity to diverse bacterial or fungal isolates. Clinical tests on 13 blinded sputum samples revealed 100% (six of six) sensitivity and 100% (seven of seven) specificity compared to culture. SHINE-TB streamlines TB diagnosis from sample to answer by combining amplification and detection while being compatible with lateral flow and lyophilization.
- 8 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (32) , eadx2067
Top Cited PapersOpen AccessA streamlined CRISPR-based test for tuberculosis detection directly from sputum
Mycobacterium tuberculosis ( Mtb ) is a major threat to global health, and there is an urgent need for affordable, simple tuberculosis (TB) diagnosis in underresourced areas. Here, we combine recombinase polymerase amplification with Cas13a and Cas12a detection to create two parallelized one-pot assays that detect two conserved elements of Mtb ( IS6110 and IS1081 ) and a human DNA internal control. These assays are compatible with lateral flow and can be readily lyophilized. Our final assay showed a limit of detection of 69.0 CFU per milliliter for Mtb H37Rv and 80.5 CFU per milliliter for Mycobacterium bovis BCG in spiked sputum, with no cross-reactivity to diverse bacterial or fungal isolates. Clinical tests on 13 blinded sputum samples revealed 100% (six of six) sensitivity and 100% (seven of seven) specificity compared to culture. SHINE-TB streamlines TB diagnosis from sample to answer by combining amplification and detection while being compatible with lateral flow and lyophilization.